SS
REGN icon

SBI Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

SBI Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190K Sell
305
-13
-4% -$8.85K ﹤0.01% 681
2026
Q1 		$246K Sell
318
-89
-22% -$68.1K 0.01% 569
2025
Q4 		$314K Buy
407
+30
+8% +$20.4K 0.01% 491
2025
Q3 		$212K Sell
377
-255
-40% -$144K 0.01% 600
2025
Q2 		$332K Buy
632
+5
+0.8% +$2.79K 0.01% 450
2025
Q1 		$398K Sell
627
-24
-4% -$16.5K 0.01% 381
2024
Q4 		$464K Buy
+651
New +$546K 0.01% 358

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SBI Securities's REGN Position: Q2 2026 in Review

SBI Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 4.1% in Q2 2026, selling an estimated $8.85K and leaving 305 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

SBI Securities first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $464K in Q4 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • SBI Securities held 305 shares of Regeneron Pharmaceuticals worth $190K as of Q2 2026.
  • SBI Securities sold 13 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.85K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #681 holding.
  • SBI Securities first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Regeneron Pharmaceuticals position peaked at $464K in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.